Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Rossari Biotech's Board has recommended a final dividend of Re. 0.50 per equity share (25% of face value) for the financial year ended March 31, 2026. This dividend is subject to approval at the upcoming AGM, with July 10, 2026, fixed as the record date for eligibility.
Jun 28 2026 12:25:25
Rossari Biotech Ltd - 543213 - Business Responsibility and Sustainability Reporting (BRSR)
Rossari Biotech's Business Responsibility and Sustainability Report for FY2025-26 indicates notable progress in ESG metrics. The company achieved improvements in energy and water intensity, reduced Scope 1 GHG emissions by 37.25%, and significantly increased waste recycling.
Jun 27 2026 01:00:30
Rossari Biotech Ltd - 543213 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Rossari Biotech's subsidiary, Unistar Thai Co. Limited, has established a new blending facility in Thailand. This facility, with an installed capacity of 5000 MTPA, is strategically positioned to serve the growing Southeast Asian market.
Jun 26 2026 17:48:32
Rossari Biotech Ltd - 543213 - Intimation Of Record Date
Rossari Biotech fixed July 10, 2026, as Record Date for dividend payment. The dividend, if declared for FY 2025-26, will be for equity shares of ₹2 each.
Jun 18 2026 16:09:50
Rossari Biotech Ltd - 543213 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Rossari Biotech informed that sellers of Unitop Chemicals Private Limited, its material unlisted subsidiary, have filed a petition challenging the arbitration award dated January 21, 2026. This legal action was taken under Section 34 of the Arbitration and Conciliation Act, 1996.
Jun 04 2026 23:41:50
Read More